Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Gel Heads Overseas

Media Release 9 August 1999

"Significant sales" are being negotiated in the United States of a seaweed-based anti-inflammatory gel that has been developed by a small Hutt Valley laboratory.

"The product is based on seaweed," says Ian Miller, of Carina Chemical Laboratories Ltd.

"What makes it different from others is the delivery agent. The seaweed agent binds the anti-inflammatory to the skin, and then drives the stuff [the fat-soluble anti-inflammatory agent] into the skin."

The research is an investment of the Public Good Science Fund, Dr Miller developed the commercially made gel for medical purposes such as skin conditions, and reducing swelling in sports injuries.

It will be distributed through pharmacies, supermarkets, health and sports shops, "and in Australia through vet shops - apparently this stuff is good for horses' legs," Dr Miller says.

It can also be used on cows' teats, which crack.

The manufactured products use materials (polysaccharides) extracted from seaweed. Part of the research has entailed chemically modifying seaweed structure and finding new uses for it.

Dr Miller has been helped in his programme by Drs Richard Furneaux and Ruth Falshaw, of Industrial Research Ltd, and Dr John Blunt, of the University of Canterbury.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>